# Chris Mansi

> Chris Mansi is a Series A investor at Viz (San Francisco) backing Health Care and Medical. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Viz](https://shizune.co/investors/profile/viz)
- Location: San Francisco, United States
- Total investments: 5
- Last investment: May 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/chrismansimd/
- Facebook: https://www.facebook.com/chrismansi

Chris Mansi is a Series A investor at Viz in San Francisco focused on Health Care and Medical. Chris Mansi is based out of San Francisco, California and is the Co-Founder,CEO, and Board Member of Viz. Chris previously worked at EDUSURG LTD as a CEO. Chris Mansi attended the University of Cambridge.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $12M–$25M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Medical | 1 | 20% |
| Oncology | 1 | 20% |
| Software | 1 | 20% |
| Wellness | 1 | 20% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Seed | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 40% |
| Israel | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NeuraLight | NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care. | $25M | Series A | May 24, 2022 |  |
| NeuraLight | NeuraLight is a VC-backed venture on a mission to transform the lives of the billions of people impacted by neurological disorders by digitizing evaluation and care. | $25M | Seed | May 24, 2022 |  |
| Canopy | Canopy provides oncology practices with a comprehensive platform for all the care that happens between visits. Canopy’s multi-channel ePRO and remote triage system enable practices to identify and prioritize patients who need help, resolve their issues using intelligent software, and generate new reimbursement streams from high-quality care. Formore information, visit www.canopycare.us. | $13M | Series A | Mar 17, 2022 |  |
| Canopy | Canopy provides oncology practices with a comprehensive platform for all the care that happens between visits. Canopy’s multi-channel ePRO and remote triage system enable practices to identify and prioritize patients who need help, resolve their issues using intelligent software, and generate new reimbursement streams from high-quality care. Formore information, visit www.canopycare.us. | $18M | Venture - Series Unknown | Mar 17, 2022 |  |
| HumanFirst | HumanFirst accelerates the adoption of patient-centered clinical trials using precision digital measures (e.g., digital biomarkers and eCOA).At HumanFirst, we offer a precision measures platform - the world’s largest AI-powered SaaS platform trusted to improve human outcomes. We provide insights, intelligence, and accuracy with validated evidencedata to precisely guide and accelerate human-centric drug development. Twenty-two of the 25 largest pharmaceutical companies in the world have used the HumanFirst platform to evaluate and enable the deployment of digital health technologies (DHTs). | $12M | Series A | May 31, 2021 |  |

5 of 5 investments shown.

## Co-investors
- [Samsung NEXT](https://shizune.co/investors/profile/samsungnext) — VC Fund, 4 deals together
- [Breyer Capital](https://shizune.co/investors/profile/breyer-capital) — VC Fund, 2 deals together
- [GSR Ventures](https://shizune.co/investors/profile/gsr-ventures-management) — VC Fund, 2 deals together
- [UpWest](https://shizune.co/investors/profile/upwest-labs) — VC Fund, 2 deals together
- [VSC Ventures](https://shizune.co/investors/profile/vsc-ventures) — VC Fund, 2 deals together
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund, 1 deal together

## About Viz

VC Fund · San Francisco, United States

Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat them. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularlydisabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes.Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce the time to treatment and improve access to care.Viz was founded in 2016 and is based in San Francisco, California.

5 contacts available at Viz.

| Name | Title | Profile |
| --- | --- | --- |
| Mike Herring | Chief Financial Officer | https://shizune.co/investors/profile/mike-herring |
| Brian Davis | DevOps & Network Engineer | https://shizune.co/investors/profile/brian-davis-bc83 |
| Chris Mansi | Co-Founder and CEO | https://shizune.co/investors/profile/chris-mansi |
| Conrad Yiu | CSO | https://shizune.co/investors/profile/conrad-yiu-011c |
| David Kizner | General Counsel and Chief Privacy Officer | https://shizune.co/investors/profile/david-kizner |

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [OurCrowd](https://shizune.co/investors/profile/ourcrowd) — VC Fund
- [Entrée Capital](https://shizune.co/investors/profile/entree-capital) — VC Fund
- [Pitango VC](https://shizune.co/investors/profile/pitango-venture-capital) — VC Fund

## Featured in investor lists
- [Wellness Angel Investors in Middle East](https://shizune.co/investors/wellness-angel-investors-middle-east)
- [Wellness Investors in Israel](https://shizune.co/investors/wellness-investors-israel)
- [Wellness Angel Investors in Israel](https://shizune.co/investors/wellness-angel-investors-israel)
- [Health Care Angel Investors in Middle East](https://shizune.co/investors/health-care-angel-investors-middle-east)
- [Health Care Angel Investors in Israel](https://shizune.co/investors/health-care-angel-investors-israel)
- [Wellness Investors in Middle East](https://shizune.co/investors/wellness-investors-middle-east)

## FAQ

### What does Chris Mansi invest in?

Chris Mansi invests primarily in Health Care, Medical and Oncology startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Chris Mansi's check size?

Chris Mansi typically joins rounds of $12M–$25M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chris Mansi participates in.

### When did Chris Mansi last invest?

The most recent investment recorded for Chris Mansi closed in May 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co